Immunological characteristics of peripheral T cells as prognostic markers for Camrelizumab and Apatinib combination therapy in advanced squamous non-small-cell lung cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Liangliang,Wu

第一单位： Laboratory of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China; Institute of Oncology, Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

作者： Liangliang,Wu ^[1] ; Xiaoyu,Zhi ^[2] ; Shengzhi,Xie ^[3] ; Keren,Li ^[4] ; Man,Chen ^[5] ; Gong,Li ^[6] ; Qiyan,Wu ^[1] ; Shunchang,Jiao ^[7] ; Jinliang,Wang ^[8] ; Tianyi,Liu ^[9]

作者单位： Laboratory of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China; Institute of Oncology, Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. ^[1] Medical School of Chinese People's Liberation Army (PLA), Beijing, China. ^[2] Department of Oncology, Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. ^[3] Hepato-Pancereato-Biliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. ^[4] Department of laboratory medicine, Hebei Yanda Lu Daopei Hospital, Langfang 065201, China. ^[5] Department of Radiation Oncology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. ^[6] Department of Oncology, Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Electronic address: jiaoshunchang301@126.com. ^[7] Department of Oncology, Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Electronic address: wangjinliang301@163.com. ^[8] Laboratory of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China; Institute of Oncology, Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Electronic address: ht514@126.com. ^[9]

关键词 Combination therapy Immunotherapy Non-small cell lung cancer Programmed cell death 1